{"created":"2025-06-12T01:55:13.082660+00:00","id":2040721,"links":{},"metadata":{"_buckets":{"deposit":"52564548-cbb5-4b94-8fb5-e9504dad562e"},"_deposit":{"created_by":7,"id":"2040721","owner":"7","owners":[7],"pid":{"revision_id":0,"type":"depid","value":"2040721"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02040721","sets":["1730444907710"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Characterization of long-term interleukin-33 administration as an animal model of pulmonary arterial hypertension","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Ikutani, Masashi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Shimizu, Shoichi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Okada, Koki","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Imami, Koshi","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Inagaki, Tadakatsu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nakaoka, Yoshikazu","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Osada, Yoshio","creatorNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nakae, Susumu","creatorNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"embargoed access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_f1cf"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"© 2024. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/","subitem_rights_language":"en"},{"subitem_rights":"This is not the published version. Please cite only the published version.","subitem_rights_language":"en"},{"subitem_rights":"この論文は出版社版ではありません。引用の際には出版社版をご確認、ご利用ください。","subitem_rights_language":"ja"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"PAH","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"IL-33","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"ILC2","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Eosinophil","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Schistosoma mansoni","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"Pulmonary arterial hypertension (PAH) is characterized by the severe obstruction of the small pulmonary arteries and concomitant high pulmonary arterial pressure, resulting in progressive right ventricular failure. Previously, we demonstrated that long-term interleukin (IL)-33 administration in mice induces severe occlusive medial hypertrophy of pulmonary arteries (PA) in the lungs, which is mediated by group 2 innate lymphoid cells (ILC2s). In response to IL-33, ILC2s accumulate around the blood vessels and produce IL-5, leading to perivascular eosinophil recruitment. In this study, we characterized IL-33-induced medial hypertrophy of PA. We demonstrated that long-term IL-33 administration causes an increase in right ventricular pressure. In IL-33-deficient mice, medial hypertrophy of PA mediated by eggs of Schistosoma mansoni was attenuated, accompanied by a partial reduction in ILC2s, eosinophils, and CD4+ T cells. In addition, proteomic analysis revealed dramatic changes in the urine samples from mice treated with IL-33 or S. mansoni eggs. Resistin-like alpha (RELMα), a pulmonary hypertension-related molecule, was commonly detected in the urine in both treatments. Large amounts of RELMα were observed in the lungs of the IL-33-treated mice. These observations suggest that IL-33-induced medial hypertrophy of PA is a useful model for studying the mechanism underlying the development of PAH and finding biomarkers to indicate the onset of PAH.","subitem_description_language":"en","subitem_description_type":"Abstract"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"Elsevier","subitem_publisher_language":"en"}]},"item_1617186660861":{"attribute_name":"Date","attribute_value_mlt":[{"subitem_date_issued_datetime":"2025-09-27","subitem_date_issued_type":"Available"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186901218":{"attribute_name":"Funding Reference","attribute_value_mlt":[{"subitem_award_numbers":{"subitem_award_number":"19K07632","subitem_award_uri":"https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-19K07632/"},"subitem_award_titles":[{"subitem_award_title":"２型自然リンパ球を起点とした血管病態形成機構の解明","subitem_award_title_language":"ja"},{"subitem_award_title":"Mechanisms of pulmonary vascular pathogenesis mediated by group 2 innate lymphoid cell","subitem_award_title_language":"en"}],"subitem_funder_identifiers":{"subitem_funder_identifier_type":"Crossref Funder","subitem_funder_identifier_type_uri":"https://doi.org/10.13039/501100001691"},"subitem_funder_names":[{"subitem_funder_name":"日本学術振興会","subitem_funder_name_language":"ja"},{"subitem_funder_name":"Japan Society for the Promotion of Science","subitem_funder_name_language":"en"}]},{"subitem_award_numbers":{"subitem_award_number":"22K07136","subitem_award_uri":"https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-22K07136/"},"subitem_award_titles":[{"subitem_award_title":"血管肥厚誘発性ILC2の動態制御機構の解明","subitem_award_title_language":"ja"},{"subitem_award_title":"Analysis for the regulatory mechanism of ILC2s in vascular hypertrophy","subitem_award_title_language":"en"}],"subitem_funder_identifiers":{"subitem_funder_identifier_type":"Crossref Funder","subitem_funder_identifier_type_uri":"https://doi.org/10.13039/501100001691"},"subitem_funder_names":[{"subitem_funder_name":"日本学術振興会","subitem_funder_name_language":"ja"},{"subitem_funder_name":"Japan Society for the Promotion of Science","subitem_funder_name_language":"en"}]},{"subitem_award_numbers":{"subitem_award_number":"21H02963","subitem_award_uri":"https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-21H02963/"},"subitem_award_titles":[{"subitem_award_title":"上皮ー樹状細胞ネットワークを介したアレルギー疾患の発症機構の解明","subitem_award_title_language":"ja"},{"subitem_award_title":"Elucidation of molecular mechanisms for development of allergic diseases via epithelial-dendritic cell networks","subitem_award_title_language":"en"}],"subitem_funder_identifiers":{"subitem_funder_identifier_type":"Crossref Funder","subitem_funder_identifier_type_uri":"https://doi.org/10.13039/501100001691"},"subitem_funder_names":[{"subitem_funder_name":"日本学術振興会","subitem_funder_name_language":"ja"},{"subitem_funder_name":"Japan Society for the Promotion of Science","subitem_funder_name_language":"en"}]}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2024-09-27","bibliographicIssueDateType":"Issued"},"bibliographicPageStart":"150750","bibliographicVolumeNumber":"734","bibliographic_titles":[{"bibliographic_title":"Biochemical and Biophysical Research Communications","bibliographic_titleLang":"en"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_ab4af688f83e57aa","subitem_version_type":"AM"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_type":"isVersionOf","subitem_relation_type_id":{"subitem_relation_type_id_text":"https://doi.org/10.1016/j.bbrc.2024.150750","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2025-09-27"}],"fileDate":[{"fileDateType":"Available","fileDateValue":"2025-09-27"}],"filename":"BBRC_734_150750.pdf","filesize":[{"value":"1.2 MB"}],"format":"application/pdf","url":{"objectType":"fulltext","url":"https://hiroshima.repo.nii.ac.jp/record/2040721/files/BBRC_734_150750.pdf"},"version_id":"63d9db5d-e797-43ce-a861-c4999d59b9bb"}]},"item_1732772494514":{"attribute_name":"備考","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"The full-text file will be made open to the public on 27 September  2025 in accordance with publisher's 'Terms and Conditions for Self-Archiving'"}]},"item_title":"Characterization of long-term interleukin-33 administration as an animal model of pulmonary arterial hypertension","item_type_id":"40036","owner":"7","path":["1730444907710"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2025-06-12"},"publish_date":"2025-06-12","publish_status":"0","recid":"2040721","relation_version_is_last":true,"title":["Characterization of long-term interleukin-33 administration as an animal model of pulmonary arterial hypertension"],"weko_creator_id":"7","weko_shared_id":-1},"updated":"2025-06-12T02:18:24.273526+00:00"}